| Baptist Health Home Care Louisville | |
| 6420 Dutchmans Parkway, Suite 360, Louisville, Kentucky 40205 | |
| (502) 454-5656 | |
| Name | Baptist Health Home Care Louisville |
|---|---|
| Location | 6420 Dutchmans Parkway, Suite 360, Louisville, Kentucky |
| Certified By | Medicare |
| Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
| Medicare ID | 187091 |
| Ownership Type | Voluntary Non Profit - Religious Affiliation |
| Service Area Zip Codes | 37232, 40003, 40006, 40007, 40010, 40011, 40013, 40014, 40019, 40022, 40023, 40025, 40026, 40027, 40031, 40041, 40046, 40047, 40050, 40055, 40056, 40057, 40059, 40065, 40067, 40068, 40070, 40071, 40075, 40076, 40077, 40109, 40118, 40150, 40165, 40177, 40202, 40203, 40204, 40205, 40206, 40207, 40208, 40209, 40210, 40211, 40212, 40213, 40214, 40215, 40216, 40217, 40218, 40219, 40220, 40222, 40223, 40228, 40229, 40241, 40242, 40243, 40245, 40258, 40272, 40291, 40299, 40601, 41501, 42001, 42002, 42003, 42020, 42025, 42027, 42029, 42031, 42032, 42036, 42039, 42040, 42041, 42044, 42048, 42049, 42051, 42053, 42054, 42066, 42069, 42071, 42076, 42079, 42082, 42085, 42086, 42088, 42211, 62908, 62910, 62923, 62931, 62938, 62941, 62943, 62947, 62953, 62956, 62960, 62972, 62985, 62995 |
| NPI Number | 1902996994 |
| Organization Name | BAPTIST HEALTHCARE SYSTEM, INC. |
| Doing Business As | BAPTIST HOSPITAL EAST HOME HEALTH AGENCY |
| Address | 6420 Dutchmans Pkwy, Suite 360, Louisville, KY 40205 |
| Phone Number | 502-454-5656 |
News Archive
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Boehringer Ingelheim today announces that Pradaxa (dabigatran etexilate) has been approved by the European Commission for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
White House negotiators and GOP lawmakers remain at odds over a deficit-reduction plan with only weeks to go before automatic spending cuts and tax increases are triggered.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 3 days ago
| Quality Rating: |
News Archive
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Boehringer Ingelheim today announces that Pradaxa (dabigatran etexilate) has been approved by the European Commission for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
White House negotiators and GOP lawmakers remain at odds over a deficit-reduction plan with only weeks to go before automatic spending cuts and tax increases are triggered.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often the home health team began their patients’ care in a timely manner | 93.4 | 95.7 |
| How often the home health team taught patients (or their family caregivers) about their drugs | 99.5 | 98.6 |
| How often the home health team checked patients’ risk of falling | 99.7 | 99.6 |
| How often the home health team checked patients for depression | 99 | 97.4 |
| How often the home health team made sure that their patients have received a flu shot for the current flu season. | 82.4 | 78.7 |
| How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 87.9 | 82.2 |
| With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 98.8 | 96.4 |
News Archive
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Boehringer Ingelheim today announces that Pradaxa (dabigatran etexilate) has been approved by the European Commission for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
White House negotiators and GOP lawmakers remain at odds over a deficit-reduction plan with only weeks to go before automatic spending cuts and tax increases are triggered.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 3 days ago
| Quality Measure | Provider | National Avg. |
|---|---|---|
| How often patients got better at walking or moving around | 76.8 | 79.6 |
| How often patients got better at getting in and out of bed | 76.2 | 81.1 |
| How often patients got better at bathing | 76 | 82.3 |
| How often patients’ breathing improved | 75.4 | 82.8 |
| How often patients’ wounds improved or healed after an operation | 92.5 | 92.3 |
| How often patients got better at taking their drugs correctly by mouth | 69.8 | 75 |
| How often home health patients had to be admitted to the hospital | 15.1 | 15.4 |
| How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 14.3 | 13 |
| How often physician-recommended actions to address medication issues were completely timely | 93.9 | 94 |
News Archive
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Boehringer Ingelheim today announces that Pradaxa (dabigatran etexilate) has been approved by the European Commission for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
White House negotiators and GOP lawmakers remain at odds over a deficit-reduction plan with only weeks to go before automatic spending cuts and tax increases are triggered.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 3 days ago
| Question Type: | Rating by Patients |
|---|---|
| Health team gave care in a professional way | |
| Health team communicated well with them | |
| Health team discussed medicines, pain, and home safety | |
| How patients rated overall care from agency |
News Archive
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Boehringer Ingelheim today announces that Pradaxa (dabigatran etexilate) has been approved by the European Commission for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
White House negotiators and GOP lawmakers remain at odds over a deficit-reduction plan with only weeks to go before automatic spending cuts and tax increases are triggered.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 3 days ago
The patient survey data of Baptist Health Home Care Louisville is compared against the national average with the color code indicators: Better than National Average Worse than National Average| Experience Measure | Provider | National Avg. |
|---|---|---|
| Percent of patients who reported that their home health team gave care in a professional way | 90 | 88 |
| Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
| Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 82 | 83 |
| Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 88 | 84 |
| Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 84 | 78 |
News Archive
Patients with clinically diagnosed neurological symptoms associated with COVID-19 are six times more likely to die in the hospital than those without the neurological complications, according to an interim analysis from the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID).
Boehringer Ingelheim today announces that Pradaxa (dabigatran etexilate) has been approved by the European Commission for the treatment and prevention of recurrence of deep vein thrombosis (DVT) and pulmonary embolism (PE).
White House negotiators and GOP lawmakers remain at odds over a deficit-reduction plan with only weeks to go before automatic spending cuts and tax increases are triggered.
Boehringer Ingelheim and Eli Lilly and Company announce new data that reinforce the efficacy and tolerability of linagliptin in people with Type 2 Diabetes and liver disease, as well as Asian people with T2D aged 65 years or older.
› Verified 3 days ago
Vna Health At Home Location: 200 High Rise Drive, Suite 373, Louisville, Kentucky 40213 Ratings: Phone: (502) 584-2456 | |
Amedisys Home Health Services Location: 13101 Magisterial Drive, Suite 101, Louisville, Kentucky 40223 Ratings: Phone: (502) 244-5441 | |
Kindred At Home Location: 710 Executive Park, Louisville, Kentucky 40207 Ratings: Phone: (502) 895-4213 | |
Baptist Health Home Care Louisville Location: 6420 Dutchmans Parkway, Suite 360, Louisville, Kentucky 40205 Ratings: Phone: (502) 454-5656 | |
Amedisys Home Health Care Services Location: 9000 Wessex Place, Suite 304, Louisville, Kentucky 40222 Ratings: Phone: (502) 429-4550 | |
Norton Home Health Location: 9510 Ormsby Station Road Suite 103, Louisville, Kentucky 40223 Ratings: Phone: (502) 423-4336 |